title: The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
abstract: The burden of disease due to chronic viral hepatitis constitutes a global threat. In many Balkan and Mediterranean countries, the disease burden due to viral hepatitis remains largely unrecognized, including in high-risk groups and migrants, because of a lack of reliable epidemiological data, suggesting the need for better and targeted surveillance for public health gains. In many countries, the burden of chronic liver disease due to hepatitis B and C is increasing due to ageing of unvaccinated populations and migration, and a probable increase in drug injecting. Targeted vaccination strategies for hepatitis B virus (HBV) among risk groups and harm reduction interventions at adequate scale and coverage for injecting drug users are needed. Transmission of HBV and hepatitis C virus (HCV) in healthcare settings and a higher prevalence of HBV and HCV among recipients of blood and blood products in the Balkan and North African countries highlight the need to implement and monitor universal precautions in these settings and use voluntary, nonremunerated, repeat donors. Progress in drug discovery has improved outcomes of treatment for both HBV and HCV, although access is limited by the high costs of these drugs and resources available for health care. Egypt, with the highest burden of hepatitis C in the world, provides treatment through its National Control Strategy. Addressing the burden of viral hepatitis in the Balkan and Mediterranean regions will require national commitments in the form of strategic plans, financial and human resources, normative guidance and technical support from regional agencies and research.
authors.affiliation: National Retrovirus Reference Center, Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece. ahatzak@med.uoa.gr
authors.forename: A
authors.initials: A
authors.lastname: Hatzakis
authors.forename: P
authors.initials: P
authors.lastname: Van Damme
authors.forename: K
authors.initials: K
authors.lastname: Alcorn
authors.forename: C
authors.initials: C
authors.lastname: Gore
authors.forename: M
authors.initials: M
authors.lastname: Benazzouz
authors.forename: S
authors.initials: S
authors.lastname: Berkane
authors.forename: M
authors.initials: M
authors.lastname: Buti
authors.forename: M
authors.initials: M
authors.lastname: Carballo
authors.forename: H
authors.initials: H
authors.lastname: Cortes Martins
authors.forename: S
authors.initials: S
authors.lastname: Deuffic-Burban
authors.forename: A
authors.initials: A
authors.lastname: Dominguez
authors.forename: M
authors.initials: M
authors.lastname: Donoghoe
authors.forename: A-N
authors.initials: AN
authors.lastname: Elzouki
authors.forename: N
authors.initials: N
authors.lastname: Ben-Alaya Bouafif
authors.forename: G
authors.initials: G
authors.lastname: Esmat
authors.forename: R
authors.initials: R
authors.lastname: Esteban
authors.forename: M
authors.initials: M
authors.lastname: Fabri
authors.forename: K
authors.initials: K
authors.lastname: Fenton
authors.forename: D
authors.initials: D
authors.lastname: Goldberg
authors.forename: I
authors.initials: I
authors.lastname: Goulis
authors.forename: C
authors.initials: C
authors.lastname: Hadjichristodoulou
authors.forename: T
authors.initials: T
authors.lastname: Hadjichristodoulou
authors.forename: T
authors.initials: T
authors.lastname: Hatzigeorgiou
authors.forename: O
authors.initials: O
authors.lastname: Hamouda
authors.forename: S
authors.initials: S
authors.lastname: Hasurdjiev
authors.forename: S
authors.initials: S
authors.lastname: Hughes
authors.forename: A
authors.initials: A
authors.lastname: Kautz
authors.forename: M
authors.initials: M
authors.lastname: Malik
authors.forename: S
authors.initials: S
authors.lastname: Manolakopoulos
authors.forename: M
authors.initials: M
authors.lastname: Matičič
authors.forename: G
authors.initials: G
authors.lastname: Papatheodoridis
authors.forename: R
authors.initials: R
authors.lastname: Peck
authors.forename: A
authors.initials: A
authors.lastname: Peterle
authors.forename: G
authors.initials: G
authors.lastname: Potamitis
authors.forename: D
authors.initials: D
authors.lastname: Prati
authors.forename: F
authors.initials: F
authors.lastname: Roudot-Thoraval
authors.forename: T
authors.initials: T
authors.lastname: Reic
authors.forename: A
authors.initials: A
authors.lastname: Sharara
authors.forename: M
authors.initials: M
authors.lastname: Shennak
authors.forename: G
authors.initials: G
authors.lastname: Shiha
authors.forename: D
authors.initials: D
authors.lastname: Shouval
authors.forename: M
authors.initials: M
authors.lastname: Sočan
authors.forename: H
authors.initials: H
authors.lastname: Thomas
authors.forename: M
authors.initials: M
authors.lastname: Thursz
authors.forename: M
authors.initials: M
authors.lastname: Tosti
authors.forename: C
authors.initials: C
authors.lastname: Trépo
authors.forename: A
authors.initials: A
authors.lastname: Vince
authors.forename: E
authors.initials: E
authors.lastname: Vounou
authors.forename: L
authors.initials: L
authors.lastname: Wiessing
authors.forename: M
authors.initials: M
authors.lastname: Manns
mesh_terms: D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D063368:Balkan Peninsula / Q000453:epidemiology; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology* / Q000209:etiology; D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D062665:Epidemiological Monitoring; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D019694:Hepatitis B, Chronic / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D019698:Hepatitis C, Chronic / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology* / Q000209:etiology; D019083:Mediterranean Region / Q000453:epidemiology; D016896:Treatment Outcome; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D000998:Antiviral Agents; D017325:Hepatitis B Vaccines
keywords: Balkan region; Mediterranean; hepatitis B; hepatitis C; hepatocellular carcinoma; northern Africa; surveillance